Embera NeuroTherapeutics Closes on $4.5 Million Continuation of Series a Financing
Drug Addiction Treatment: Embera NeuroTherapeutics Closes on .5 Million Continuation of Series A Financing
Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for smoking cessation and other addictions, announced today that it has closed on $ 4.5 million in a continuation of its Series A financing.
Drug Addiction Treatment – Yahoo! News Search Results
Find More Drug Addiction Treatment Information…